Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed with results

Key Signals

3 with results78% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (3)
P 1 (1)
P 2 (3)
P 4 (2)

Trial Status

Completed7
Terminated2
Unknown1
Recruiting1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (11)

Research Network

Activity Timeline